Nicholas J. Sarlis

Induction chemotherapy followed by concurrent chemoradiotherapy (sequential chemoradiotherapy) versus concurrent chemoradiotherapy alone in locally advanced head and neck cancer (PARADIGM): a randomised phase 3 trial

Robert I. Haddad, Anne O’Neill, Guilherme Rabinowits et al. · The Lancet Oncology · 2013 · 735 citations

Advanced Head, Concurrent Chemoradiotherapy, Radiation Therapy +10

Outcomes of Patients with Differentiated Thyroid Carcinoma Following Initial Therapy

Jacqueline Jonklaas, Nicholas J. Sarlis, Danielle R. Litofsky et al. · Thyroid · 2006 · 689 citations

Surgical Oncology, Health Sciences, Medicine +14

Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial

Marshall R. Posner, Jochen H. Lorch, Olga Goloubeva et al. · Annals of Oncology · 2011 · 485 citations · Full text

Tax 324, Epidemiology, Human Papillomavirus Vaccines +9

Induction chemotherapy with cisplatin and fluorouracil alone or in combination with docetaxel in locally advanced squamous-cell cancer of the head and neck: long-term results of the TAX 324 randomised phase 3 trial

Jochen H. Lorch, Olga Goloubeva, Robert I. Haddad et al. · The Lancet Oncology · 2011 · 436 citations

Tax 324, Medicine, Treatment Resistance +10

Racial Survival Disparity in Head and Neck Cancer Results from Low Prevalence of Human Papillomavirus Infection in Black Oropharyngeal Cancer Patients

Kathleen Settle, Marshall R. Posner, Lisa M. Schumaker et al. · Cancer Prevention Research · 2009 · 294 citations · Full text